BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against 22nd Century, Vale, Revolution Lighting, and Astec and Encourages Investors to Contact the Firm
24 févr. 2019 18h47 HE | Bragar Eagel & Squire
NEW YORK, Feb. 24, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of 22nd Century Group, Inc.,...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sogou, Wayfair, DBV Technologies, and Ferroglobe and Encourages Investors to Contact the Firm
24 févr. 2019 18h37 HE | Bragar Eagel & Squire
NEW YORK, Feb. 24, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Sogou Inc., Wayfair Inc.,...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AxoGen, Markel, Maxar, and Wirecard and Encourages Investors to Contact the Firm
24 févr. 2019 18h08 HE | Bragar Eagel & Squire
NEW YORK, Feb. 24, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of AxoGen, Inc., Markel...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Uxin, Avon, Bristow, and Molson Coors and Encourages Investors to Contact the Firm
24 févr. 2019 18h07 HE | Bragar Eagel & Squire
NEW YORK, Feb. 24, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Uxin Limited, Avon Products,...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DXC Technology, Immunomedics, Natural Health, and Maiden Holdings and Encourages Investors to Contact the Firm
24 févr. 2019 18h06 HE | Bragar Eagel & Squire
NEW YORK, Feb. 24, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of DXC Technology Company,...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. is Investigating Diplomat Pharmacy, Inc. (DPLO) on Behalf of Stockholders and Encourages DPLO Investors to Contact the Firm
22 févr. 2019 18h23 HE | Bragar Eagel & Squire
NEW YORK, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Diplomat Pharmacy, Inc. (NYSE: DPLO).  Our investigation concerns whether...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Is Investigating The Kraft Heinz Company (KHC) on Behalf of Stockholders and Encourages KHC Investors to Contact the Firm
22 févr. 2019 18h16 HE | Bragar Eagel & Squire
NEW YORK, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against The Kraft Heinz Company (NASDAQ: KHC).  Our investigation concerns whether Kraft...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of MedEquities, TCF Financial, and Kinderhook on Behalf of Stockholders and Encourages Investors to Contact the Firm
22 févr. 2019 09h28 HE | Bragar Eagel & Squire
NEW YORK, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that it is investigating potential claims on behalf of stockholders of MedEquities Realty Trust, Inc.,...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Immune Design Corp. (IMDZ) on Behalf of Stockholders and Encourages IMDZ Investors to Contact the Firm
22 févr. 2019 09h27 HE | Bragar Eagel & Squire
NEW YORK, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Immune Design Corp. (NASDAQ: IMDZ) on behalf of...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. is Investigating Vanda Pharmaceuticals Inc. (VNDA) on Behalf of Stockholders and Encourages VNDA Investors to Contact the Firm
21 févr. 2019 20h44 HE | Bragar Eagel & Squire
NEW YORK, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Vanda Pharmaceuticals Inc. (NASDAQ: VNDA).  Our investigation concerns whether...